Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Huo

Showing results (331-340 of 353) with videos related to

Pageof 36
Sort By:
British Journal of Haematology|May 5, 2023
Causative germline variant p.Y259C of DDX41 recurrently identified in acute lymphoblastic leukaemiaLi Huo, Zhibo Zhang, Haixia Zhou, et al.
Clinical Interventions in Aging|February 27, 2020
Teriparatide in East Asian Postmenopausal Women with Osteoporosis in a Real-World Setting: A Baseline Analysis of the Asia and Latin America Fracture Observational Study (ALAFOS)Chung-Hwan Chen, Seung-Jae Lim, Jong-Keon Oh, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 14, 2026
Pharmacokinetics and Dosimetry of [<sup>68</sup>Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 StudyWei Fan, Yonghong Li, Hongcheng Shi, et al.
The Journal of Clinical Endocrinology and Metabolism|January 28, 2025
Glucose Metabolic Abnormalities and Their Interaction With Defective Phosphate Homeostasis in Tumor-induced OsteomalaciaRuoTong Zhou, Ruizhi Jiajue, Xiaolin Ni, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 10, 2021
Early Discrimination Between Tumor-Induced Rickets/Osteomalacia and X-Linked Hypophosphatemia in Chinese Children and Adolescents: A Retrospective Case-Control StudyRuizhi Jiajue, Xiaolin Ni, Chenxi Jin, et al.
Frontiers in Endocrinology|June 30, 2022
Bone Volumetric Density, Microarchitecture, and Estimated Bone Strength in Tumor-Induced Rickets/Osteomalacia <i>Versus</i> X-linked Hypophosphatemia in Chinese AdolescentsRuizhi Jiajue, Xiaolin Ni, Chenxi Jin, et al.
EJNMMI Research|March 1, 2026
A phase II study evaluating pharmacokinetics and dosimetry of <sup>177</sup>Lu-PSMA-617 radioligand therapy in Chinese participants with progressive metastatic castration-resistant prostate cancerHongcheng Shi, Jianming Guo, Wei Fan, et al.
Cancer Discovery|July 1, 2021
Tumor Microenvironment-Derived R-spondins Enhance Antitumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade TherapyYuting Tang, Qian Xu, Liang Hu, et al.
Annals of the New York Academy of Sciences|September 3, 2022
Tumor-induced osteomalacia combined with acromegaly: A case reportXiang Li, Xiaolin Ni, Xiaofeng Chai, et al.
Hepatobiliary Surgery and Nutrition|August 25, 2020
Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinomaJianzhen Lin, Xu Yang, Junyu Long, et al.
Pageof 36

Showing results (331-340 of 353) with videos related to

Sort By:
Pageof 36
British Journal of Haematology|May 5, 2023
Causative germline variant p.Y259C of DDX41 recurrently identified in acute lymphoblastic leukaemiaLi Huo, Zhibo Zhang, Haixia Zhou, et al.
Clinical Interventions in Aging|February 27, 2020
Teriparatide in East Asian Postmenopausal Women with Osteoporosis in a Real-World Setting: A Baseline Analysis of the Asia and Latin America Fracture Observational Study (ALAFOS)Chung-Hwan Chen, Seung-Jae Lim, Jong-Keon Oh, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 14, 2026
Pharmacokinetics and Dosimetry of [<sup>68</sup>Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 StudyWei Fan, Yonghong Li, Hongcheng Shi, et al.
The Journal of Clinical Endocrinology and Metabolism|January 28, 2025
Glucose Metabolic Abnormalities and Their Interaction With Defective Phosphate Homeostasis in Tumor-induced OsteomalaciaRuoTong Zhou, Ruizhi Jiajue, Xiaolin Ni, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 10, 2021
Early Discrimination Between Tumor-Induced Rickets/Osteomalacia and X-Linked Hypophosphatemia in Chinese Children and Adolescents: A Retrospective Case-Control StudyRuizhi Jiajue, Xiaolin Ni, Chenxi Jin, et al.
Frontiers in Endocrinology|June 30, 2022
Bone Volumetric Density, Microarchitecture, and Estimated Bone Strength in Tumor-Induced Rickets/Osteomalacia <i>Versus</i> X-linked Hypophosphatemia in Chinese AdolescentsRuizhi Jiajue, Xiaolin Ni, Chenxi Jin, et al.
EJNMMI Research|March 1, 2026
A phase II study evaluating pharmacokinetics and dosimetry of <sup>177</sup>Lu-PSMA-617 radioligand therapy in Chinese participants with progressive metastatic castration-resistant prostate cancerHongcheng Shi, Jianming Guo, Wei Fan, et al.
Cancer Discovery|July 1, 2021
Tumor Microenvironment-Derived R-spondins Enhance Antitumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade TherapyYuting Tang, Qian Xu, Liang Hu, et al.
Annals of the New York Academy of Sciences|September 3, 2022
Tumor-induced osteomalacia combined with acromegaly: A case reportXiang Li, Xiaolin Ni, Xiaofeng Chai, et al.
Hepatobiliary Surgery and Nutrition|August 25, 2020
Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinomaJianzhen Lin, Xu Yang, Junyu Long, et al.
Pageof 36